Compounds > ketorolac tromethamine
Page last updated: 2024-08-25

ketorolac tromethamine and Dermatitis Medicamentosa

ketorolac tromethamine has been researched along with Dermatitis Medicamentosa in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bevelacqua, V; Guarneri, C; Polimeni, G1
Abarzuza, R; Cristóbal, JA; Del Buey, MA; Mínguez, E; Rodríguez, NA; Sierra, J1

Other Studies

2 other study(ies) available for ketorolac tromethamine and Dermatitis Medicamentosa

ArticleYear
Embolia cutis medicamentosa (Nicolau syndrome).
    QJM : monthly journal of the Association of Physicians, 2012, Volume: 105, Issue:11

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Embolism; Female; Humans; Injections, Subcutaneous; Ketorolac Tromethamine; Skin Diseases, Vascular; Skin Ulcer; Syndrome

2012
[Eyelid contact allergic eczema caused by topical ketorolac tromethamine 0.5%].
    Archivos de la Sociedad Espanola de Oftalmologia, 2006, Volume: 81, Issue:4

    Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Atopic; Drug Eruptions; Eyelid Diseases; Humans; Ketorolac Tromethamine; Male; Ophthalmic Solutions; Skin Tests; Treatment Outcome

2006